Vericel Corporation

VCEL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2009
Revenue $182.0K
Cost of Revenue $112.0K
Gross Profit $70.0K
Gross Margin 38.5%
Operating Expenses
Research & Development $11.3M
SG&A Expense $5.0M
Operating Income $-16.2M
Operating Margin -8,884.1%
Interest Expense $73.0K
Pretax Income —
Income Tax Expense —
Net Income $-16.1M
Net Margin -8,824.7%
EPS (Basic) $-0.90
EPS (Diluted) $-0.90
Shares Outstanding (Basic) 17.9M
Shares Outstanding (Diluted) 17.9M
Dividends Per Share —
← Newer Page 3 of 3 Older →